Sale of IAM Shares Held by CMIC in Association with Listing of AIM on TSE Mothers

Press Release, August 18, 2006

Sale of IAM Shares Held by CMIC in Association

with Listing of AIM on TSE Mothers

The Tokyo Stock Exchange today approved the listing of the Institute of Applied Medicine, Inc. (IAM) on Mothers. IAM is a subsidiary of CMIC. As a result of the listing, CMIC plans to sell a portion of the shares CMIC holds in IAM. The details of the planned sale are as follows.
1. Outline of the sale
(1) Seller
CMIC
Co.,
Ltd.
(2) Shares to be offered for
sale

Institute of Applied Medicine, Inc. common stock
(3) Number of shares to be
offered
400,000
(4) Offer price

To be decided

2. Other
notes
At the IAM board of directors meeting today, it was resolved to invite subscriptions for 400,000 shares to be issued in conjunction with the listing of IAM on Mothers.
Overview of the Institute of Applied Medicine, Inc. (as of July 31, 2006)
(1) Firm name

Institute of Applied Medicine, Inc. (IAM)
(2) Head Office

32 Nishi 2-chome, Kita 2 Jo, Chuo-ku, Sapporo Hokkaido
(3) Foundation

December 24, 1980
(4) President
Hiromitsu
Ohno
(5) Capital
725,000,000
yen
(6) Main business
Testing agency specialized in the analysis of medicines:
provides outsourcing services related to the quality assurance of pharmaceutical products and pharmacokinetics to pharmaceuticals related businesses
(7) Number of employees
63

Overview of CMIC Co., Ltd. (as of March 31, 2006)
(1) Firm name

CMIC Co., Ltd.
(2) Head
Office
7-10-4
(3) Foundation

March 14, 1985
(4) President
Kazuo
Nakamura
(5) Capital
3,084,750,000
yen
(6) Main business
CMIC Group will further develop comprehensive support
services on regulatory consultation clinical research, manufacture, and marketing of pharmaceutical products for pharmaceutical companies and bio ventures with an emphasis on CRO services. CMIC contributes to maximize values of our clients.
(7) Number of employees
1,230（Consolidated）